Skip to Content
Merck
All Photos(1)

Documents

16636

Millipore

UTI ChromoSelect Agar, modified

NutriSelect® Plus, suitable for microbiology

Synonym(s):

Urinary Tract Infection Agar, modified

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41171606
NACRES:
NA.85

sterility

non-sterile

Quality Level

200

form

powder

shelf life

limited shelf life, expiry date on the label

composition

agar, 15 g/L
beef extract, 4 g/L
casein enzymic hydrolysate, 4 g/L
chromogenic mixture, 12.44 g/L
peptic digest of animal tissue, 18 g/L

manufacturer/tradename

NutriSelect® Plus

final pH

7.2±0.3 (25 °C)

application(s)

clinical testing
clinical testing
environmental
food and beverages
veterinary
microbiology

storage temp.

2-8°C

suitability

nonselective and differential for Enterococcus spp.
nonselective and differential for Escherichia coli
nonselective and differential for Klebsiella spp.
nonselective and differential for Proteus spp.
nonselective and differential for Pseudomonas spp.
nonselective and differential for Staphylococcus spp.
nonselective and differential for coliforms
nonselective and differential for enterobacteriaceae

Related Categories

General description

Urinary tract infection (UTI) ChromoSelect Agar is chromogenic differential medium for identification, differentiation, and conformation of enteric bacteria from specimens such as urine, water, or food which may contain large number of Proteus species as well as potentially pathogenic Gram-positive organisms. Based on these characteristics, modified UTI ChromoSelect Agar is suggested for use in place of MacConkey Agar.

Application

Urinary tract infection (UTI) ChromoSelect Agar, modified has been used in the cell culture of Escherichia coli. It has also been used in the culturing of Klebsiella pneumoniae and Escherichia coli to plate mouse thigh muscle homogenates for bacterial count.

Preparation Note

Suspend 55.4 g in 1 litre distilled water. Boil to dissolve the medium completely. Sterilize by autoclaving at 1 bar pressure (121°C) for 15 minutes. Cool to 50°C and pour into sterile petri plates.

Other Notes

Chromogenic medium for detecting and identifying Enterobacteria, Proteus species, and certain potentially pathogenic Gram-positive organisms.

Footnote

We offer two media types: the superior granulated GranuCult® and the cost-efficient powdered NutriSelect® culture media, depending on your needs.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.

Legal Information

GRANUCULT is a registered trademark of Merck KGaA, Darmstadt, Germany
NutriSelect is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCM1993
BCCL6172
BCCK7875
BCCH8666
BCCD9576

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Willames M B S Martins et al.
mSphere, 5(5) (2020-10-09)
This study provides the genomic characterization and clinical description of bloodstream infections (BSI) cases due to ST15 KPC-2 producer Klebsiella pneumoniae Six KPC-K. pneumoniae isolates were recovered in 2015 in a tertiary Brazilian hospital and were analyzed by whole-genome sequencing
M P Friedman et al.
Journal of clinical microbiology, 29(11), 2385-2389 (1991-11-01)
Random urine samples from hospitalized patients (n = 550) and seeded sterile filtered urine samples (n = 730) were used to test a membrane filtration technique, Qualture (Future Medical Technologies International, Inc., West Palm Beach, Fla.), for the detection and
Yang Yu et al.
The Journal of antimicrobial chemotherapy, 74(1), 87-95 (2018-10-23)
The emergence of NDM- and MCR-1-co-producing Escherichia coli has compromised the use of carbapenems and colistin, which are critically important in clinical therapy, and represents a severe threat to public health worldwide. Here, we demonstrate synergism of colistin combined with
Muhammad Usman Qamar et al.
Pakistan journal of pharmaceutical sciences, 32(5(Supplementary)), 2305-2309 (2020-01-03)
Metallo-β-lactamase (MBL) producing Escherichia coli are an emerging and serious threat to public health sector around the globe. MBL are spreading via plasmids to the host pathogens and produce resistance against carbapenems and left limited or no treatment option. Therefore
M. Pezzlo
Clin. Microbiol. Reviews, 1, 168-168 (1998)

Articles

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service